Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sam Guglani"'
Autor:
Enjie Ibrahim, William H. Dean, Nicholas Price, Ahmed Gomaa, Gareth Ayre, Sam Guglani, Ahmed Sallam
Publikováno v:
Case Reports in Ophthalmological Medicine, Vol 2012 (2012)
We present a case of a sixty-year-old female who presented with sudden onset of painless loss of vision in one eye due to a perforated corneal ulcer, following three months of treatment with gefitinib, a selective epidermal growth factor receptor (EG
Externí odkaz:
https://doaj.org/article/762b9d6c3b2f42fb88554ea70353262b
Autor:
Sam Guglani
Publikováno v:
The Lancet. 401:805
Autor:
Sam Guglani
Publikováno v:
Lancet (London, England). 398(10317)
Autor:
Libby Sallnow, Richard Smith, Sam H Ahmedzai, Afsan Bhadelia, Charlotte Chamberlain, Yali Cong, Brett Doble, Luckson Dullie, Robin Durie, Eric A Finkelstein, Sam Guglani, Melanie Hodson, Bettina S Husebø, Allan Kellehear, Celia Kitzinger, Felicia Marie Knaul, Scott A Murray, Julia Neuberger, Seamus O'Mahony, M R Rajagopal, Sarah Russell, Eriko Sase, Katherine E Sleeman, Sheldon Solomon, Ros Taylor, Mpho Tutu van Furth, Katrina Wyatt
Publikováno v:
Lancet (London, England). 399(10327)
Autor:
Sam Guglani
Publikováno v:
The Lancet. 399:1375
Autor:
Krishnakumar Garadi, Clare L Killick-Cole, Alastair Wilkins, Juliana Redondo, Paul D. White, Harry R Haynes, Sam Guglani, Kelly M Hares, Kathreena M Kurian, Kevin C Kemp, William G B Singleton, Jonathan R Stevens
Publikováno v:
Histopathology. 70:1030-1043
© 2016 John Wiley & Sons Ltd Aims: PPARα agonists are in current clinical use as hypolipidaemic agents and show significant antineoplastic effects in human glioblastoma models. To date however, the expression of PPARα in large-scale glioblastoma d
Autor:
Sam, Guglani
Publikováno v:
The Lancet. 394:2145
Autor:
Petra Jankowska, M Darby, Clare E Hooper, John E Harvey, Anna J Morley, Adam Dangoor, Paul D. White, T Hall, Najib M. Rahman, Jeremy P Braybrooke, S. A. Lowndes, David T Arnold, David O. Hall, Amelia O Clive, Julie Searle, E. De Winton, Iain D. Lyburn, Nick A Maskell, Sam Guglani, Vidan Masani
Publikováno v:
British Journal of Cancer
Background: The effect of chemotherapy on health-related quality of life (HRQoL) in malignant pleural mesothelioma (MPM) is poorly understood. Patient-individualised prognostication and prediction of treatment response from chemotherapy is useful but
Autor:
Sam, Guglani
Publikováno v:
The Lancet. 394:111
Autor:
Sam Guglani
Publikováno v:
Lancet (London, England). 388(10051)